Study finds the risk of recurrence of active disease in older patients with MS after discontinuing therapy

FHS
June 23, 2023
5:26 am

An article published today in the journal Lancet Neurology evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.

Legend signs $100M deal with Novartis for next CAR-T bets, following up on Janssen success

Legend Biotech, which came to the fore in cell therapy when Johnson & Johnson took a major bet in 2017 on what would become Carvykti,

November 14, 2023

CDC: U.S. Falls Short in Improving QoL for Older People With HIV

In 2022, none of the 5 quality-of-life (QoL) goals set by the U.S. National HIV/AIDS Strategy (NHAS) were met for adults with HIV ages 50

September 14, 2024

New hope for preventing preterm births: IL-6R blockade reduces neonatal mortality

The role of interleukin (IL)-6 and IL-1α in sterile intraamniotic inflammation (SIAI), a condition associated with preterm birth (PTB).

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.